Boston Scientific Resumes Most, Not All, Implantable Defibrillator Shipments

Boston Scientific resumed shipments of virtually all of its implantable defibrillators April 15 following retrospective clearance by FDA of two manufacturing changes

More from Archive

More from Medtech Insight